Granules India Ltd share price was down by -1.44% from the previous closing price of ₹564.45. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals ...

Recent studies have highlighted the functional capacity of neutrophils as powerful mediators of tissue inflammation. Granule-packaged proteases and reactive oxygen intermediates, which are ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children. Jan 30, 2025 14:05 ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13,703.32 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.